Axsome Therapeutics Inc

General

Total Cases16

Active Cases7

Patents94

CourtsD. New Jersey D. Delaware

TypeOperating Company

Elite Ratings

--

axsome-therapeutics

axsome-therapeutics

Ratings

Experience

Grade

Trend

DCT

--

--

--

PTAB

--

--

--

CAFC

--

--

--

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered	Case	Description
09/16/24	Axsome Malta Ltd v. Alkem Laboratories Ltd 2:24-CV-09209 ( D. NJ )	Corporate Disclosure Statement by AXSOME MALTA LTD., AXSOME THERAPEUTICS, INC.. (LIZZA, CHARLES) (Entered: 09/16/2024)
09/16/24	Axsome Malta Ltd v. Alkem Laboratories Ltd 2:24-CV-09209 ( D. NJ )	COMPLAINT against ALKEM LABORATORIES LTD., AUROBINDO PHARMA LIMITED, AUROBINDO PHARMA USA, INC., HETERO LABS LIMITED UNIT-V, HETERO LABS LTD., HETERO USA INC., HIKMA PHARMACEUTICALS USA INC. ( Filing and Admin fee $ 405 receipt number ANJDC-15667470) , Related Case Selected, filed by AXSOME THERAPEUTICS, INC., AXSOME MALTA LTD.. (Attachments: # [1] Civil Cover Sheet)(LIZZA, CHARLES) (Entered: 09/16/2024) COMPLAINT against ALKEM LABORATORIES LTD., AUROBINDO PHARMA LIMITED, AUROBINDO PHARMA USA, INC., HETERO LABS LIMITED UNIT-V, HETERO LABS LTD., HETERO USA INC., HIKMA PHARMACEUTICALS USA INC. ( Filing and Admin fee $ 405 receipt number ANJDC-15667470) , Related Case Selected, filed by AXSOME THERAPEUTICS, INC., AXSOME MALTA LTD.. (Attachments: # [1] Civil Cover Sheet)(LIZZA, CHARLES) (Entered: 09/16/2024)
09/10/24	Axsome Therapeutics Inc v. Teva Pharmaceuticals Inc 2:23-CV-01695 ( D. NJ )	Letter from Axsome to the Hon. Leda D. Wettre, U.S.M.J.. (BATON, WILLIAM)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 09/10/2024) Letter from Axsome to the Hon. Leda D. Wettre, U.S.M.J.. (BATON, WILLIAM)NOTICE TO COUNSEL: Counsel is advised that pursuant to Local Civil Rule 5.3(c)(2), a single, consolidated motion to seal shall be filed within 14 days following the completed briefing of the materials sought to be sealed, or within 14 days following the date on which the last of such materials was filed under temporary seal if the motion is resolved, unless otherwise directed by the Court. (Entered: 09/10/2024)
09/10/24	Axsome Therapeutics Inc v. Teva Pharmaceuticals Inc 2:23-CV-01695 ( D. NJ )	LETTER ORDER granting one-day extension of time through 9/10/2024 to submit joint status letter. Signed by Magistrate Judge Leda D. Wettre on 9/10/2024. (lag, ) (Entered: 09/10/2024)
09/09/24	Axsome Therapeutics Inc v. Teva Pharmaceuticals Inc 2:23-CV-01695 ( D. NJ )	Letter from Plaintiffs to the Hon. Leda D. Wettre, U.S.M.J.. (BATON, WILLIAM) (Entered: 09/09/2024)
09/09/24	Axsome Malta Ltd v. Alkem Laboratories Ltd 2:23-CV-20354 ( D. NJ )	STIPULATION AND ORDER of Dismissal regarding Defendant, SANDOZ INC.. SANDOZ INC. terminated. Signed by Judge Madeline Cox Arleo on 9/9/2024. (jd, ) (Entered: 09/09/2024)
09/09/24	Axsome Malta Ltd v. Alkem Laboratories Ltd 2:23-CV-20354 ( D. NJ )	STIPULATION AND ORDER of Dismissal regarding Defendant, SANDOZ INC.. SANDOZ INC. terminated. Signed by Judge Madeline Cox Arleo on 9/9/2024. (jd, ) (Entered: 09/09/2024)
08/21/24	Axsome Therapeutics Inc v. Teva Pharmaceuticals Inc 2:23-CV-01695 ( D. NJ )	Letter from Plaintiffs to the Hon. Michael E. Farbiarz, U.S.D.J.. (Attachments: # 1 Joint Claim Construction and Prehearing Statement)(LIZZA, CHARLES) (Entered: 08/21/2024)
08/21/24	Axsome Malta Ltd v. Aurobindo Pharma USA Inc 2:24-CV-08624 ( D. NJ )	Corporate Disclosure Statement by AXSOME MALTA LTD., AXSOME THERAPEUTICS, INC.. (LIZZA, CHARLES) (Entered: 08/21/2024)
08/21/24	Axsome Malta Ltd v. Aurobindo Pharma USA Inc 2:24-CV-08624 ( D. NJ )	Corporate Disclosure Statement by AXSOME MALTA LTD., AXSOME THERAPEUTICS, INC.. (LIZZA, CHARLES) (Entered: 08/21/2024)